Vistagen Therapeutics (VTGN) Receivables - Other (2021 - 2025)
Vistagen Therapeutics (VTGN) has disclosed Receivables - Other for 5 consecutive years, with $74000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 50.34% to $74000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $74000.0 through Dec 2025, down 50.34% year-over-year, with the annual reading at $130000.0 for FY2025, 36.27% down from the prior year.
- Receivables - Other hit $74000.0 in Q4 2025 for Vistagen Therapeutics, down from $92000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $380000.0 in Q2 2023 to a low of $40600.0 in Q1 2021.
- Historically, Receivables - Other has averaged $168513.3 across 5 years, with a median of $167000.0 in 2024.
- Biggest five-year swings in Receivables - Other: skyrocketed 392.61% in 2022 and later plummeted 51.05% in 2024.
- Year by year, Receivables - Other stood at $44000.0 in 2021, then soared by 354.55% to $200000.0 in 2022, then increased by 11.6% to $223200.0 in 2023, then plummeted by 33.24% to $149000.0 in 2024, then plummeted by 50.34% to $74000.0 in 2025.
- Business Quant data shows Receivables - Other for VTGN at $74000.0 in Q4 2025, $92000.0 in Q3 2025, and $111000.0 in Q2 2025.